FURTHER CHARACTERIZATION OF THE THROMBASTHENIA-RELATED IDIOTYPE OG - ANTIIDIOTYPE DEFINES A NOVEL EPITOPE(S) SHARED BY FIBRINOGEN B-BETA CHAIN, VITRONECTIN, AND VON-WILLEBRAND-FACTOR AND REQUIRED FOR BINDING TO BETA(3)
Y. Gruel et al., FURTHER CHARACTERIZATION OF THE THROMBASTHENIA-RELATED IDIOTYPE OG - ANTIIDIOTYPE DEFINES A NOVEL EPITOPE(S) SHARED BY FIBRINOGEN B-BETA CHAIN, VITRONECTIN, AND VON-WILLEBRAND-FACTOR AND REQUIRED FOR BINDING TO BETA(3), The Journal of experimental medicine, 180(6), 1994, pp. 2259-2267
A patient (OG) with Glanzmann thrombasthenia became refractory to plat
elet transfusion after the production of an immunoglobulin G (IgG) iso
antibody (Ab1) specific for the integrin subunit beta(3). To determine
the frequency at which the OG idiotype is found in the general popula
tion and in immune-mediated disease states, we developed a rabbit poly
clonal antibody (Ab2) specific for affinity-puritied OG anti-beta(3) F
ab. The binding of Ab2 to Ab1 is inhibited by purified alpha(IIb)beta(
3). Ab2 also binds to IgG specific for alpha(IIb)beta(3) obtained from
one nonrelated Glanzmann thrombasthenia patient ES who has developed
isoantibodies of similar specificity. On the other hand, Ab2 does not
recognize alpha(IIb)beta(3)-specific antibodies produced by two Glanzm
ann thrombasthenia patients, AF and LUC, who have developed isoantibod
ies with specificities distinct from that of the OG isoantibody. Moreo
ver, Ab2 does not recognize alpha(IIb)beta(3)-specific antibodies deve
loped by three representative patients with (autoimmune) thrombocytope
nic purpura or six representative patients with alloimmune thrombocyto
penias, nor does it bind to IgG from any of 13 nonimmunized individual
s. We have found that Ab2 also binds to selected protein ligands of al
pha(IIb)beta(3) namely, fibrinogen, vitronectin, and von Willebrand fa
ctor, but not to other protein ligands or control proteins, such a fib
ronectin, type I collagen, and albumin. The epitope(s) recognized by A
b2 on each adhesive protein are either very similar or identical since
each protein can inhibit the binding of Ab2 to any of the other prote
ins. The epitope on fibrinogen recognized by Ab2 resides in the B beta
chain, and is likely contained within the first 43 amino acids from t
he NH2 terminus. Since OG IgG inhibits fibrinogen binding to alpha(IIb
)beta(3), the specificity of the OG idiotype defines a novel binding m
otif for the integrin alpha(IIb)beta(3) that is shared by fibrinogen,
vitronectin, and von Willebrand factor, but distinct from previously d
escribed RGD-containing sites on the fibrinogen, A alpha chain or the
fibrinogen gamma chain COOH-terminal decapeptide site. Our findings re
ported here represent an excellent example of molecular mimicry in whi
ch an antigen-selected, IgG inhibitor of alpha(IIb)beta(3) function sh
ares a novel recognition sequence common to three physiologic protein
ligands of that receptor.